Verrica Pharmaceuticals Inc
NASDAQ:VRCA

Watchlist Manager
Verrica Pharmaceuticals Inc Logo
Verrica Pharmaceuticals Inc
NASDAQ:VRCA
Watchlist
Price: 7.56 USD -4.55%
Market Cap: 71.7m USD

Wall Street
Price Targets

VRCA Price Targets Summary
Verrica Pharmaceuticals Inc

Wall Street analysts forecast VRCA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRCA is 16.66 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.

Lowest
Price Target
10.1 USD
34% Upside
Average
Price Target
16.66 USD
120% Upside
Highest
Price Target
21 USD
178% Upside
Verrica Pharmaceuticals Inc Competitors:
Price Targets
XERS
Xeris Biopharma Holdings Inc
66% Upside
002332
Zhejiang Xianju Pharmaceutical Co Ltd
32% Upside

Revenue
Forecast

Revenue Estimate
Verrica Pharmaceuticals Inc

The compound annual growth rate of Verrica Pharmaceuticals Inc's revenue for the next 4 years is 111%.

N/A
Past Growth
111%
Estimated Growth
Estimates Accuracy
9%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Verrica Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Verrica Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-74%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VRCA's stock price target?
Price Target
16.66 USD

According to Wall Street analysts, the average 1-year price target for VRCA is 16.66 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.

What is Verrica Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
111%

The compound annual growth rate of Verrica Pharmaceuticals Inc's revenue for the next 4 years is 111%.

Back to Top